Dimension Therapeutics, Inc
DMTX
DMTX was delisted on the 6th of November, 2017.
54 hedge funds and large institutions have $170M invested in Dimension Therapeutics, Inc in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
32% more capital invested
Capital invested by funds: $129M → $170M (+$41.3M)
4% more funds holding
Funds holding: 52 → 54 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
Top Buyers
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.59M |
| 2 |
JP Morgan Chase
New York
|
-$749K |
| 3 |
Goldman Sachs
New York
|
-$548K |
| 4 |
AG
Artal Group
Luxembourg
|
-$293K |
| 5 |
SIM
Spark Investment Management
New York
|
-$169K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MA
51
MUFG Americas
New York
| $4K | -$1.59K | -220 | -33% |
|
|
BJ
52
BlackRock Japan
Tokyo,
Japan
| $2K | +$1.98K | +274 | New |
|
53
Barclays
London,
United Kingdom
| $1K | +$557 | +77 | New |
|
|
TCIM
54
TIAA CREF Investment Management
New York
| $324 | -$7.84K | -1,085 | -3% |
|
|
ARTA
55
A.R.T. Advisors
New York
| – | -$134K | -22,497 | Closed |
|
|
HCM
56
Highbridge Capital Management
New York
| – | -$123K | -20,573 | Closed |
|
|
NI
57
Numeric Investors
Boston,
Massachusetts
| – | -$75K | -12,542 | Closed |
|
|
SO
58
STRS Ohio
Columbus,
Ohio
| – | -$13K | -1,800 | Closed |
|
DMTX Hedge Fund Activity: Q3 2016 in Review
54 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q3 2016, worth a combined $170M — up 32% from $129M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new DMTX positions and 4 closed out — a net gain of 2 holders — while 17 added to existing stakes and 17 trimmed.
The largest buyer was Vanguard Group, adding an estimated $1.78M. The largest seller was PFM Health Sciences, cutting an estimated $1.59M.
- 54 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q3 2016, up from 52 in Q2 2016.
- Funds reported $170M of Dimension Therapeutics, Inc stock for Q3 2016, up 32% quarter-over-quarter.
- 6 funds opened new Dimension Therapeutics, Inc positions in Q3 2016 and 4 closed out, a net change of +2 holders.
- The largest Dimension Therapeutics, Inc buyer in Q3 2016 was Vanguard Group, an estimated $1.78M added.
- The largest Dimension Therapeutics, Inc seller in Q3 2016 was PFM Health Sciences, an estimated $1.59M sold.
Based on aggregated 13F filings for Q3 2016.